Kaspar Broch1, Arne K Andreassen2, Thor Ueland3, Annika E Michelsen3, Wenche Stueflotten2, Pål Aukrust4, Svend Aakhus2, Lars Gullestad5. 1. Department of Cardiology, Oslo University Hospital, Rikshospitalet, Oslo, Norway; K. G. Jebsen Research Centre and Center for Heart Failure Research, Faculty of Medicine, University of Oslo, Oslo, Norway. Electronic address: kaspar.broch@ous-hf.no. 2. Department of Cardiology, Oslo University Hospital, Rikshospitalet, Oslo, Norway. 3. Research Institute for Internal Medicine, Oslo, Norway. 4. Research Institute for Internal Medicine, Oslo, Norway; Section for Clinical Immunology and Infectious Diseases, Oslo University Hospital, Rikshospitalet, Oslo, Norway. 5. Department of Cardiology, Oslo University Hospital, Rikshospitalet, Oslo, Norway; K. G. Jebsen Research Centre and Center for Heart Failure Research, Faculty of Medicine, University of Oslo, Oslo, Norway.
Abstract
BACKGROUND: Elevated levels of soluble ST2 (sST2) are associated with adverse outcome in heart failure. A change in sST2 levels has also been shown to presage outcome. In vitro, ST2 expression is induced by myocardial stress and pro-inflammatory stimuli. The determinants of sST2 levels in vivo, and how they vary with clinical status over time, have not been well described. In a cohort of patients with non-ischemic heart failure, we aimed to assess the association between sST2-levels and hemodynamic parameters reflecting right and left ventricular pre- and afterload, and how these vary with time and clinical status. METHODS: We prospectively recruited 102 patients with a left ventricular ejection fraction of 26 ± 10% and a diagnosis of idiopathic dilated cardiomyopathy based on patient history, clinical examination, echocardiography and coronary angiography. Patients went through extensive baseline work-up and were re-examined after one year. Subsequently, heart transplantations and deaths were recorded. Determinants of sST2 were analyzed at baseline and after one year. Soluble ST2 was measured with a highly sensitive immunoassay. RESULTS: Soluble ST2 levels were associated with hemodynamic parameters, but these associations were attenuated with clinical improvement. Soluble ST2 was elevated in patients with severe symptoms, but did not vary with etiology, viral presence or the amount of myocardial fibrosis. Heart rate and right atrial pressure remained independent predictors of sST2 on multiple regression analysis. CONCLUSIONS: Our results imply that in non-ischemic heart failure, sST2 reflects hemodynamic stress rather than pathogenic processes in the myocardium.
BACKGROUND: Elevated levels of soluble ST2 (sST2) are associated with adverse outcome in heart failure. A change in sST2 levels has also been shown to presage outcome. In vitro, ST2 expression is induced by myocardial stress and pro-inflammatory stimuli. The determinants of sST2 levels in vivo, and how they vary with clinical status over time, have not been well described. In a cohort of patients with non-ischemic heart failure, we aimed to assess the association between sST2-levels and hemodynamic parameters reflecting right and left ventricular pre- and afterload, and how these vary with time and clinical status. METHODS: We prospectively recruited 102 patients with a left ventricular ejection fraction of 26 ± 10% and a diagnosis of idiopathic dilated cardiomyopathy based on patient history, clinical examination, echocardiography and coronary angiography. Patients went through extensive baseline work-up and were re-examined after one year. Subsequently, heart transplantations and deaths were recorded. Determinants of sST2 were analyzed at baseline and after one year. Soluble ST2 was measured with a highly sensitive immunoassay. RESULTS: Soluble ST2 levels were associated with hemodynamic parameters, but these associations were attenuated with clinical improvement. Soluble ST2 was elevated in patients with severe symptoms, but did not vary with etiology, viral presence or the amount of myocardial fibrosis. Heart rate and right atrial pressure remained independent predictors of sST2 on multiple regression analysis. CONCLUSIONS: Our results imply that in non-ischemic heart failure, sST2 reflects hemodynamic stress rather than pathogenic processes in the myocardium.
Authors: Hilde M Norum; Kaspar Broch; Annika E Michelsen; Ida G Lunde; Tove Lekva; Aurelija Abraityte; Christen P Dahl; Arnt E Fiane; Arne K Andreassen; Geir Christensen; Svend Aakhus; Pål Aukrust; Lars Gullestad; Thor Ueland Journal: J Cardiovasc Transl Res Date: 2017-05-04 Impact factor: 4.132
Authors: Kaspar Broch; Arne K Andreassen; Einar Hopp; Trond P Leren; Helge Scott; Fredrik Müller; Svend Aakhus; Lars Gullestad Journal: Open Heart Date: 2015-10-09
Authors: Santiago Roura; Carolina Gálvez-Montón; David de Gonzalo-Calvo; Ana Gámez Valero; Paloma Gastelurrutia; Elena Revuelta-López; Cristina Prat-Vidal; Carolina Soler-Botija; Aida Llucià-Valldeperas; Isaac Perea-Gil; Oriol Iborra-Egea; Francesc E Borràs; Josep Lupón; Vicenta Llorente-Cortés; Antoni Bayes-Genis Journal: J Cell Mol Med Date: 2017-05-29 Impact factor: 5.310
Authors: Cheyenne C S Tseng; Manon M H Huibers; Lonneke H Gaykema; Erica Siera-de Koning; Faiz Z Ramjankhan; Alan S Maisel; Nicolaas de Jonge Journal: Eur J Clin Invest Date: 2018-02-02 Impact factor: 4.686
Authors: Aurelija Abraityte; Ida G Lunde; Erik T Askevold; Annika E Michelsen; Geir Christensen; Pål Aukrust; Arne Yndestad; Arnt Fiane; Arne Andreassen; Svend Aakhus; Christen P Dahl; Lars Gullestad; Kaspar Broch; Thor Ueland Journal: Sci Rep Date: 2017-06-14 Impact factor: 4.379
Authors: David Binas; Hanna Daniel; Anette Richter; Volker Ruppert; Klaus-Dieter Schlüter; Bernhard Schieffer; Sabine Pankuweit Journal: Open Heart Date: 2018-02-26
Authors: Stefan Stojkovic; Alexandra Kaider; Lorenz Koller; Mira Brekalo; Johann Wojta; Andre Diedrich; Svitlana Demyanets; Thomas Pezawas Journal: J Cell Mol Med Date: 2018-02-04 Impact factor: 5.295
Authors: Vincent L Aengevaeren; Roland R J VAN Kimmenade; Maria T E Hopman; Niels VAN Royen; James V Snider; James L Januzzi; Keith P George; Thijs M H Eijsvogels Journal: Med Sci Sports Exerc Date: 2019-03 Impact factor: 5.411